THC

tripsit

marinol

Vérifier sur tripsit

isomerdesign

THC

Vérifier sur isomerdesign

isomerdesign

cis-Δ9-THC

Vérifier sur isomerdesign

isomerdesign

inverse-Δ9-THC

Vérifier sur isomerdesign

pubchem

Dronabinol

Vérifier sur pubchem

druglab

Cannabis

Vérifier sur druglab

drugmap

Marinol

Vérifier sur drugmap

wiki

Tetrahydrocannabinol

Vérifier sur wiki

wiki

Cis-THC

Vérifier sur wiki

SMILES:CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(C)=CC21

InChI:InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3

InChI key:CYQFCXCEBYINGO-UHFFFAOYSA-N

Synonymes: UNII-7J8897W37S, (-)-trans-delta9-Tetrahydrocannabinol,Delta9-Tetrahydrocannabinol 250 microg/mL in Acetonitrile,NSC 134454,BIDD:GT0427, delta(sup 1)-Thc,(-)-trans-delta9-Tetrahydrocannabinol,(-)-.DELTA.9-THC, Trans-delta9-Tetrahydrocannabinol,(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol,L-trans-delta9-Tetrahydrocannabinol, Delta(9)-Tetrahydrocannabinol, delta(1)-Tetrahydrocannabinol,6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, trans-,(-)-trans-Delta1-Tetrahydrocannabinol,(-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol, Delta(9)-Tetrahydrocannibinol,delta(sup 1)-Thc,delta(sup 1)-Tetrahydrocannabinol, (-)-DELTA9-Tetrahydrocannabinol,BDBM60994,.DELTA.9-trans-Tetrahydrocannabinol,Epitope ID:224552, Abbott 40566,(-)-Delta9-THC (Dronabinol) 1.0 mg/ml in Methanol,(6AR,10AR)-6,6,9-TRIMETHYL-3-PENTYL-6H,6AH,7H,8H,10AH-BENZO[C]ISOCHROMEN-1-OL, Delta9-THC,QCD 84924, Promega,CHEBI:66964,6H-Dibenzo[b, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-,L-delta1-trans-Tetrahydrocannabinol,(-)-.DELTA.9-Tetrahydrocannabinol,(6aR-trans)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol,Tetrahydrocannabinol, Delta1-Tetrahydrocannabinol,INT-0010/06,1-trans-.delta.(sup9)-tetrahydrocannabinol, Delta9-Tetrahydrocannabinol (VAN),Dronabinol (USP/INN),(-)-.delta.(sup9)-trans-Tetrahydrocannabinol, L-trans-delta9-Tetrahydrocannabinol,delta(9)-THC,L-trans-.delta.9-Tetrahydrocannabinol, 1-trans-delta(sup 9)-Tetrahydrocannabinol,DRONABINOL [VANDF], Delta(sup 9)-Thc,delta9-trans-Tetrahydrocannabinol,J882F, (l)-delta(sup 1)-Tetrahydrocannabinol,THC, (L)-delta1-Tetrahydrocannabinol,Tetrahydrocannabinols (-)-trans-.delta.9-form,(-)-delta9-trans-Tetrahydrocannabinol,(10R,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol, Hashish,delta(9)-Tetrahydrocannibinol, Dronabinol [USAN:INN], Delta9-Tetrahydrocannabinol,Tox21_112616, Delta(sup 1)-Tetrahydrocannabinol,(l)-delta1-Tetrahydrocannabinol, Namisol, DELTA1-THC,US9416103, Delta9-THC,δ9--tetrahydrocannabinol,6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol(DeltaE-9-THC),(-)-Delta9-Tetrahydrocannabinol (Delta9-THC) 100 microg/mL in Methanol,6,6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-dibenzo(b,d)pyran-1-ol,Compassia, delta1-THC,delta1-Tetrahydrocannabinol (VAN),DRONABINOL [MART.],trans-Δ9-THC,7J8897W37S, TETRAHYDROCANNABINOL,CAS-1972-08-3, (-)-delta9-Tetrahydrocannabinol,C06972, Omegaven,(-)-Delta9-Tetrahydrocannabinol (Delta9-THC) 1000 microg/mL in Methanol,DRONABINOL [USAN], MaxEPA, delta(sup 9)-Thc,TETRAHYDROCANNABINOL,GTPL2424,DRONABINOL [HSDB], (-)-delta1-Tetrahydrocannabinol, QCD 84924,Dronabinolum, (-)-DELTA9-trans-Tetrahydrocannabinol,thc,BDBM50007391,delta(1)-Tetrahydrocannabinol,(6aR-trans)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol,3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-ol,delta1-Tetrahydrocannabinol,.delta.-9-tetrahydrocannabinol,trans-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol, (-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol, Delta(9)-tetrahydrocannabinol,cesamet,(-)-.DELTA.9-trans-Tetrahydrocannabinol,SCI-110 component dronabinol, Dronabinol (USP/INN),delta-Tetrahydrocannabinol (THC), L-delta1-Tetrahydrocannabinol,(L)-.delta.1-Tetrahydrocannabinol, Fish oils, omega-3 fatty acid-high,CHEMBL465, 1972/8/3, delta(9)-Tetrahydrocannibinol,delta(sup 9)-Thc,6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-,DRONABINOL [INN], Sonergx,dronabinol, 1-trans-delta9-Tetrahydrocannabinol,DTXCID101327, Fats and Glyceridic oils, fish, n-3 fatty acid-high,Dronabinol [USAN:USP:INN],TCI, Delta(sup 9)-Tetrahydrocannabinol, (-)-delta(sup9)-trans-Tetrahydrocannabinol, 9-tetrahydrocannabinol,(-)-delta1-Tetrahydrocannabinol,Namisol, Delta-THC,Cannabinol, tetrahydro- (6CI),Abbott 40566,delta 9-Tetrahydrocannabinol, Marinol (TN), SP 104,8,8-Dimethyl-11-methylene-5-pentyl-3,4,8a,9,10,11,12,12a-octahydro-2H,8H-1,7-dioxa-benzo[c]phenanthrene, Delta(9)-THC, Trans-delta-9-Tetrahydrocannabinol,(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol,NSC-134454,(6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol, THC-delta-9,SP-104,ABBOTT-40566,CCRIS 4726,Q190067, (-)-3,4-trans-Delta1-Tetrahydrocannabinol,L-.delta.1-Tetrahydrocannabinol, Ganja,Dronabinol (Synthetic), Delta(sup9)-THC, 1-trans-delta-9-Tetrahydrocannabinol,6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol,.DELTA.1-Tetrahydrocannabinol,Deltanyne,14C-.DELTA.1-Tetrahydrocannabinol,PDSP2_000714,delta9-thc,syndros, Cannabis resin, delta(9)-Tetrahydrocannabinol,Dronabinol, delta1-Tetrahydrocannabinol,Cannabinol, Delta1-tetrahydro- (7CI), Trans-DELTA9-Tetrahydrocannabinol, delta-9-THC,(-)-trans-Delta9-THC,(-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol(l)-delta(sup 1)-Tetrahydrocannabinol,INT-0010,DRONABINOL [USP MONOGRAPH],trans-delta9-Tetrahydrocannabinol,.delta.(sup9)-THC,(-)-(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol,SP 104,D00306,1-trans-delta(sup9)-tetrahydrocannabinol, (-)-trans-Delta1-Tetrahydrocannabinol, THC, Relivar, Cannabinol, Delta1-tetrahydro-(7CI), 9-ene-Tetrahydrocannabinol, Cannabinol, tetrahydro-(6CI),(6AR,10AR)-6,6,9-TRIMETHYL-3-PENTYL-6A,7,8,10A-TETRAHYDRO-6H-DIBENZO(B,D)PYRAN-1-OL,.delta.-9-THC,delta9-Tetrahydrocannabinol (VAN),delta(9)-Tetrahydrocannabinol,1-trans-delta9-Tetrahydrocannabinol, (-)-delta9-(trans)-Tetrahydrocannabinol,Tetrahydrocannabinols (-)-delta1-3,4-trans-form, delta9-Tetrahydrocannabinol, Deltanyne, Delta9-trans-Tetrahydrocannabinol, 1-trans-delta(sup9)-tetrahydrocannabinol,Dronabinolum [Latin],δ9-thc,DB00470,(-)-.DELTA.1-3,4-TRANS-TETRAHYDROCANNABINOL,delta9-tetrahydrocannabinol, (-)-trans-DELTA9-Tetrahydrocannabinol,1-trans-delta-9-Tetrahydrocannabinol, Delta9-Tetrahydrocannabinol solution, (-)-delta9-trans-Tetrahydrocannabinol,Cannabinol, 1-trans-.delta.(sup9)-tetrahydro-,(l)-delta(sup 1)-Tetrahydrocannabinol,DTXSID6021327, SP,TETRAHYDROCANNABINOL, DELTA-9 TRANS,delta-9-Tetrahydrocannabinol,Marinol (TN),cis-Δ9-THC,6465-30-1,delta(sup 9)-Tetrahydrocannabinol, Delta(1)-Tetrahydrocannabinol,QCD-84924,6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-, Dronabinolum,Δ1-THC,inverse-Δ9-THC, Delta-9-tetrahydrocannabinol, 6H-Dibenzo, L-delta(sup 1)-tetrahydrocannabinol,(+/-)-delta9-Tetrahydrocannabinol, delta-9-tetrahydrocannabinol,.DELTA.1-THC, delta(9)-THC, DELTA1-Tetrahydrocannabinol, Trans-tetrahydrocannabinol, Delta(1)-THC, (-)-DELTA9-THC,DRONABINOL [ORANGE BOOK],Syndros,(-)-Delta9-THC (Dronabinol) 5.0 mg/ml in Methanol, (-)-DELTA1-Tetrahydrocannabinol, Delta1-Tetrahydrocannabinol (VAN),delta-9 Tetrahydrocannabinol, DELTA9-trans-Tetrahydrocannabinol,(-)-trans-.DELTA.9-Tetrahydrocannabinol,DTXSID001038830,delta-9-tetrahydrocannabinol,(-)-Delta9-THC (Dronabinol) 0.1 mg/ml in Methanol,Δ9-THC,DELTA9-THC,Relivar,(-)-.DELTA.1-Tetrahydrocannabinol,(S)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol,DEA No. 7369, Delta(sup 1)-Thc,6H-Dibenzo[b, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, 1-trans-D9-Tetrahydrocannabinol,Cannabinol, delta1-tetrahydro-,6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol(delta9-THC(delta9-tetrahydrocannabinol)),.DELTA.9-Tetrahydrocannabinol,delta9-Tetrahydrocannabinol, CAT-310,9-tetrahydrocannabinol, Drona binol,Cannabinol, .DELTA.1-tetrahydro-, (l)-delta1-Tetrahydrocannabinol, DRG-0138,6H-dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-,DRG-0138, Marincap, Tetrahydrocannabinols (-)-delta1-3,4-trans-form,L-.delta.1-trans-Tetrahydrocannabinol, Compassia,delta1-THC,NSC134454, L-delta1-trans-Tetrahydrocannabinol, Dronabinolum [Latin],DRONABINOL [WHO-DD],6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol, (-)-trans-Delta9-THC,6H-Dibenzo[b, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, trans-, Delta1-THC,CAT-310, delta9-THC, Omega-3-Fatty acid, Pro-Mega,(-)-3,4-trans-Delta1-Tetrahydrocannabinol, Tetrahydrocannabinol delta9,Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol, 14C-DELTA1-Tetrahydrocannabinol,SCHEMBL4609,6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-,3ls4,1-trans-delta(sup 9)-Tetrahydrocannabinol,trans-.DELTA.9-Tetrahydrocannabinol,Tetrahydrocannabinol delta9, Tetranabinex, Fish oils, n-3 fatty acid-high,(-)-delta9-Tetrahydrocannabinol,Cannabinol, 1-trans-delta(sup 9)-tetrahydro-,Delta-9-Tetrahydrocannabinol, United States Pharmacopeia (USP) Reference Standard, 9-delta-Tetrahydrocannabinol,HSDB 6471,.DELTA.9-THC,TETRAHYDROCANNABINOLS (-)-TRANS-.DELTA.9-FORM [MI], Delta-9-THC,(6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol,Marinol,1972-08-3,delta9-THC,delta-9-THC

Similarités

Pouvoir identifier des molécules similaires à celle que nous étudions peut permettre d'inférer certaines de ses propriétés. Il existe plusieurs façons de mesurer la similitude entre les molécules, par leur structure, leurs effets, leurs interactions pharmacologiques, etc. Vous pouvez trouver ci-dessous des molécules similaires selon divers critères et des outils que nous avons développés. Pour comprendre les limitations de ces comparaisons, il est crucial de se référer toujours à la méthodologie utilisée pour mesurer ces similitudes.Veuillez noter : Ces informations sont fournies uniquement à des fins informatives et ne doivent pas être interprétées comme des conseils médicaux.

Pour mesurer la similarité structurelle, nous utilisons la méthode Mol2vecmol2vec, qui est un réseau neuronal qui traite les molécules et les transforme en points dans l'espace, de telle sorte que les molécules avec des sous-structures chimiquement apparentées soient transformées en points proches dans l'espace.

Propriétés moléculaires

En utilisant le modèle de KGPT Deep Learning, nous prédisons plusieurs propriétés de la molécule. Les prédictions sont regroupées par l'ensemble de données utilisé pour les obtenir. Avec chaque prédiction, nous fournissons un graphique montrant la distribution des valeurs prédites sur l'ensemble d'entraînement/test/validation. Cela donne une estimation de la fiabilité du modèle.

Description: A dataset focused on predicting the inhibitory effects of molecules on the enzyme beta-secretase 1 (BACE1). BACE1 inhibition is a potential target for Alzheimer's disease treatment.
Class
TrainValTest
2.88-3.70-1.36
Description: A dataset providing insights on the ability of molecules to penetrate the blood-brain barrier. Crucial for understanding the potential of molecules as central nervous system drugs.
p_np
TrainValTest
-2.24-3.290.40
Description: This dataset deals with the FDA approval status and clinical trial toxicity of molecules. Important for understanding the safety and regulatory status of compounds.
CT_TOX
TrainValTest
-0.49-0.78-0.91
FDA_APPROVED
TrainValTest
0.53-1.27-0.50
Description: A dataset that predicts the solubility of molecules in water. Solubility is an essential property influencing bioavailability and the potential formulation of a drug.
logSolubilitylog(mol/L)
-1.98
TrainValTest
Description: This dataset is centered on predicting the free energy when a molecule is dissolved in water. The energy changes can affect molecular interactions in biological systems.
freesolvkcal/mol
-0.63
TrainValTest
Description: A dataset predicting the lipophilicity of molecules. Lipophilicity is a crucial factor affecting the distribution, metabolism, and excretion of drugs in the body.
lipoAlogP
1.72
TrainValTest
Description: This dataset gives insights into the metabolic stability of molecules. High metabolic stability often results in a longer half-life, influencing drug dosage and frequency.
low
TrainValTest
-0.17-3.50-2.88
high
TrainValTest
0.72-3.55-0.49
27 entries
12 entries
617 entries

Perspectives avancées

Nous fournissons des analyses plus avancées sur les interactions d'une molécule avec le métabolisme humain, les sites de liaison, etc.

Affinités

Affinités de liaison avec une liste de 61 sites de liaison prédéfinis. Ces affinités sont utilisées pour calculer les similarités d'interactions.

Interaction de cette molécule avec le métabolisme

Nous utilisons un modèle d'apprentissage en profondeur pour prédire les interactions de cette molécule avec le métabolisme. Consultez la source pour comprendre la méthodologie.

Réactions qui métabolisent cette molécule
Aromatic OH-glucuronidation BTMR0166
Enzymes: 2.4.1.17
Reagents

Metabolite: InChI=1S/C27H38...

Sulfonation of phenolic compound BTMR1376
Enzymes: 2.8.2.1
Methylation of phenolic compound BTMR1377
Enzymes: 2.1.1.25
Hydroxylation of antepenultimate aliphatic secondary carbon BTMR1072
Enzymes: CYP1A2 CYP2E1
Hydroxylation of non-terminal aliphatic carbon adjacent to aromatic ring BTMR1077
Reagents

Metabolite: InChI=1S/C21H30...

Hydroxylation of alicyclic secondary carbon BTMR1068
Hydroxylation of alicyclic secondary carbon BTMR1068
Reagents

Metabolite: InChI=1S/C21H30...

Hydroxylation of penultimate aliphatic secondary carbon BTMR1074
Reagents

Metabolite: InChI=1S/C21H30...

Epoxidation of alkene BTMR0110
Reagents

Metabolite: InChI=1S/C21H30...

Hydroxylation of terminal methyl BTMR1061
Reagents

Metabolite: InChI=1S/C21H30...

Terminal desaturation BTMR1190
Reagents

Metabolite: InChI=1S/C21H28...

Hydroxylation of alicyclic tertiary carbon BTMR1243
Enzymes: CYP1A2
Reagents

Metabolite: InChI=1S/C21H30...

Hydroxylation of alicyclic tertiary carbon BTMR1243
Enzymes: CYP1A2
Reagents

Metabolite: InChI=1S/C21H30...

Hydroxylation of methyl carbon adjacent to aliphatic ring BTMR0054
Hydroxylation of methyl carbon adjacent to aliphatic ring BTMR0054
Réactions qui produisent du métabolisme à partir de cette molécule
Hydrolysis of carboxylic acid ester BTMR0143
Enzymes: 3.1.1.1
Decarboxylation of fused benzene BTMR0284
Enzymes: Unspecified bacterial decarboxylase
Hydrolysis of carboxylic acid ester BTMR0143
Enzymes: 3.1.1.1
Products
Hydrolysis of carboxylic acid ester BTMR0143
Enzymes: 3.1.1.1
Sulfohydrolysis of arylsulfate BTMR0556
Enzymes: 3.1.6.1
Hydrolysis of carboxylic acid ester BTMR0143
Enzymes: 3.1.1.1
O-Dealkylation BTMR0052
Hydrolysis of carboxylic acid ester BTMR0143
Enzymes: 3.1.1.1